Gene therapy strategies have been riddled with technical problems and much-publicized risks. In the April 19
They found that when they used replication-defective retroviruses to deliver a marker gene to mouse bone marrow cells, the animals developed leukemia. Li
The risk of cancer is another factor that must be considered in future gene therapy trials.